Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more. read more
Padlock Therapeutics CEO & Leadership Team Ratings
Michael Gilman and the Padlock Therapeutics leadership team are scored a C by 3 employees placing it in the Bottom 45% of companies sized 10,000+ Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.
Based on 23 ratings, the Leadership score of 65/100 combines employee feedback on their CEO (33/100), Manager (71/100), and Executive Team (68/100).
Michael Gilman Padlock Therapeutics CEO Rating
Bottom 5% Compared to other companies of similar size in BostonF
33 / 100
Michael Gilman the CEO of Padlock Therapeutics received an average score of 33 from Padlock Therapeutics employees.Padlock Therapeutics Manager Rating
Top 35% Compared to other companies of similar size in BostonB
71 / 100
Padlock Therapeutics Executive Team Rating
Top 40% Compared to other companies of similar size in BostonB-
68 / 100
×